CROSSJECT

ALCJ Euronext / Paris Santé & Biotech France
1.98
2.28 %

Crossject est une entreprise biopharmaceutique développant des systèmes d'injection sans aiguille pour l'administration de médicaments dans des cas d'urgence médicale.

Performance & Momentum

6 Months 12.97 %
1 Year 4.85 %
3 Years 47.92 %
5 Years

Similar stocks to CROSSJECT

Anantys Community

Be the first to share your analysis on CROSSJECT.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases